FOXO1 differentially regulates both normal and diabetic wound healing

Journal of Cell Biology

Volumn 209, Issue 2, 2015, Pages 289-303

  Zhang, Chenying ^a,b   Ponugoti, Bhaskar ^b   Tian, Chen ^b   Xu, Fanxing ^b,c   Tarapore, Rohinton ^b   Batres, Angelika ^b   Alsadun, Sarah ^b   Lim, Jason ^b   Dong, Guangyu ^b   Graves, Dana T ^b  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CHEMOKINE; GLUCOSE; INSULIN; SERINE PROTEINASE INHIBITOR; TRANSCRIPTION FACTOR FKHR; TUMOR NECROSIS FACTOR; ANTIDIABETIC AGENT; CCL20 PROTEIN, MOUSE; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, MOUSE; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MESSENGER RNA; SERPINB1A PROTEIN, MOUSE; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DIABETES MELLITUS; GENE DELETION; GENE SILENCING; GENETIC TRANSCRIPTION; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING; ANIMAL; APOPTOSIS; CELL CULTURE; CELL MOTION; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HUMAN; KNOCKOUT MOUSE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CCL20; CHROMATIN IMMUNOPRECIPITATION; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KERATINOCYTES; MALE; MICE; MICE, KNOCKOUT; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERPINS; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 84964402986     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201409032     Document Type: Article

References (54)

1. Al-Mulla, F., S.J. Leibovich, I.M. Francis, and M.S. Bitar. 2011. Impaired TGF-β signaling and a defect in resolution of inflammation contribute to delayed wound healing in a female rat model of type 2 diabetes. Mol. Biosyst. 7:3006-3020. http://dx.doi.org/10.1039/c0mb00317d.
2. Alikhani, M., Z. Alikhani, C. Boyd, C.M. MacLellan, M. Raptis, R. Liu, N. Pischon, P.C. Trackman, L. Gerstenfeld, and D.T. Graves. 2007. Advanced glycation end products stimulate osteoblast apoptosis via the MAP kinase and cytosolic apoptotic pathways. Bone. 40:345-353. http://dx.doi.org/10.1016/j.bone.2006.09.011.
3. Alikhani, M., S. Roy, and D.T. Graves. 2010. FOXO1 plays an essential role in apoptosis of retinal pericytes. Mol. Vis. 16:408-415.
4. Andriessen, M.P., B.H. van Bergen, K.I. Spruijt, I.H. Go, J. Schalkwijk, and P.C. van de Kerkhof. 1995. Epidermal proliferation is not impaired in chronic venous ulcers. Acta Derm. Venereol. 75:459-462.
5. Ashcroft, G.S., S.J. Mills, and J.J. Ashworth. 2002. Ageing and wound healing. Biogerontology. 3:337-345. http://dx.doi.org/10.1023/A:1021399228395.
6. Ashcroft, G.S., M.J. Jeong, J.J. Ashworth, M. Hardman, W. Jin, N. Moutsopoulos, T. Wild, N. McCartney-Francis, D. Sim, G. McGrady, et al. 2012. Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing. Wound Repair Regen. 20:38-49. http://dx.doi.org/10.1111/j.1524-475X.2011.00748.x.
7. Barthel, A., D. Schmoll, and T.G. Unterman. 2005. FoxO proteins in insulin action and metabolism. Trends Endocrinol. Metab. 16:183-189. http://dx.doi.org/10.1016/j.tem.2005.03.010.
8. Battiprolu, P.K., B. Hojayev, N. Jiang, Z.V. Wang, X. Luo, M. Iglewski, J.M. Shelton, R.D. Gerard, B.A. Rothermel, T.G. Gillette, et al. 2012. Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice. J. Clin. Invest. 122:1109-1118. http://dx.doi.org/10.1172/JCI60329.
9. Behl, Y., P. Krothapalli, T. Desta, S. Roy, and D.T. Graves. 2009. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats. Diabetes. 58:917-925. http://dx.doi.org/10.2337/db08-0537.
10. Bos, D.C., W.L. de Ranitz-Greven, and H.W. de Valk. 2011. Advanced glycation end products, measured as skin autofluorescence and diabetes complications: a systematic review. Diabetes Technol. Ther. 13:773-779. http://dx.doi.org/10.1089/dia.2011.0034.
11. Coulombe, P.A. 2003. Wound epithelialization: accelerating the pace of discovery. J. Invest. Dermatol. 121:219-230. http://dx.doi.org/10.1046/j.1523-1747.2003.12387.x.
12. Dasu, M.R., and I. Jialal. 2013. Amelioration in wound healing in diabetic tolllike receptor-4 knockout mice. J. Diabetes Complications. 27:417-421. http://dx.doi.org/10.1016/j.jdiacomp.2013.05.002.
13. Decline, F., and P. Rousselle. 2001. Keratinocyte migration requires α2β1 integrin-mediated interaction with the laminin 5 γ2 chain. J. Cell Sci. 114:811-823.
14. Eijkelenboom, A., and B.M. Burgering. 2013. FOXOs: signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14:83-97. http://dx.doi.org/10.1038/nrm3507.
15. Gailit, J., M.P. Welch, and R.A. Clark. 1994. TGF-β1 stimulates expression of keratinocyte integrins during re-epithelialization of cutaneous wounds. J. Invest. Dermatol. 103:221-227. http://dx.doi.org/10.1111/1523-1747.ep12393176.
16. Gary Sibbald, R., and K.Y. Woo. 2008. The biology of chronic foot ulcers in persons with diabetes. Diabetes Metab. Res. Rev. 24(S1, Suppl 1):S25-S30. http://dx.doi.org/10.1002/dmrr.847.
17. Gkogkolou, P., and M. Böhm. 2012. Advanced glycation end products: Key players in skin aging? Dermatoendocrinol. 4:259-270. http://dx.doi.org/10.4161/derm.22028.
18. Glasser, J., and A. Barth. 1982. Diabetic wound healing and the case for supplemental treatment with topical insulin. J. Foot Surg. 21:117-121.
19. Goova, M.T., J. Li, T. Kislinger, W. Qu, Y. Lu, L.G. Bucciarelli, S. Nowygrod, B.M. Wolf, X. Caliste, S.F. Yan, et al. 2001. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am. J. Pathol. 159:513-525. http://dx.doi.org/10.1016/S0002-9440(10)61723-3.
20. Goren, I., E. Müller, D. Schiefelbein, U. Christen, J. Pfeilschifter, H. Mühl, and S. Frank. 2007. Systemic anti-TNFα treatment restores diabetesimpaired skin repair in ob/ob mice by inactivation of macrophages. J. Invest. Dermatol. 127:2259-2267. http://dx.doi.org/10.1038/sj.jid.5700842
21. Hardman, M.J., E. Emmerson, L. Campbell, and G.S. Ashcroft. 2008. Selective estrogen receptor modulators accelerate cutaneous wound healing in ovariectomized female mice. Endocrinology. 149:551-557. http://dx.doi.org/10.1210/en.2007-1042.
22. Huang, H., and D.J. Tindall. 2007. Dynamic FoxO transcription factors. J. Cell Sci. 120:2479-2487. http://dx.doi.org/10.1242/jcs.001222.
23. Jacobsen, J.N., B. Steffensen, L. Häkkinen, K.A. Krogfelt, and H.S. Larjava. 2010. Skin wound healing in diabetic β6 integrin-deficient mice. APMIS. 118:753-764. http://dx.doi.org/10.1111/j.1600-0463.2010.02654.x.
24. Kayal, R.A., M. Siqueira, J. Alblowi, J. McLean, N. Krothapalli, D. Faibish, T.A. Einhorn, L.C. Gerstenfeld, and D.T. Graves. 2010. TNF-α mediates diabetes-enhanced chondrocyte apoptosis during fracture healing and stimulates chondrocyte apoptosis through FOXO1. J. Bone Miner. Res. 25:1604-1615. http://dx.doi.org/10.1002/jbmr.59.
25. Lan, C.C., I.H. Liu, A.H. Fang, C.H. Wen, and C.S. Wu. 2008. Hyperglycaemic conditions decrease cultured keratinocyte mobility: implications for impaired wound healing in patients with diabetes. Br. J. Dermatol. 159: 1103-1115.
26. Liang, C.C., A.Y. Park, and J.L. Guan. 2007. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2:329-333. http://dx.doi.org/10.1038/nprot.2007.30.
27. Lima, M.H., A.M. Caricilli, L.L. de Abreu, E.P. Araújo, F.F. Pelegrinelli, A.C. Thirone, D.M. Tsukumo, A.F. Pessoa, M.F. dos Santos, M.A. de Moraes, et al. 2012. Topical insulin accelerates wound healing in diabetes by enhancing the AKT and ERK pathways: a double-blind placebo-controlled clinical trial. PLoS ONE. 7:e36974. http://dx.doi.org/10.1371/journal.pone.0036974.
28. Lohwasser, C., D. Neureiter, B. Weigle, T. Kirchner, and D. Schuppan. 2006. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J. Invest. Dermatol. 126:291-299. http://dx.doi.org/10.1038/sj.jid.5700070.
29. Lund, L.R., K.A. Green, A.A. Stoop, M. Ploug, K. Almholt, J. Lilla, B.S. Nielsen, I.J. Christensen, C.S. Craik, Z. Werb, et al. 2006. Plasminogen activation independent of uPA and tPA maintains wound healing in genedeficient mice. EMBO J. 25:2686-2697. http://dx.doi.org/10.1038/sj.emboj.7601173.
30. Moulik, P.K., R. Mtonga, and G.V. Gill. 2003. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 26:491-494. http://dx.doi.org/10.2337/diacare.26.2.491.
31. Ni, Y.G., N. Wang, D.J. Cao, N. Sachan, D.J. Morris, R.D. Gerard, M. Kuro-O, B.A. Rothermel, and J.A. Hill. 2007. FoxO transcription factors activate Akt and attenuate insulin signaling in heart by inhibiting protein phosphatases. Proc. Natl. Acad. Sci. USA. 104:20517-20522. http://dx.doi.org/10.1073/pnas.0610290104.
32. Paik, J.H., R. Kollipara, G. Chu, H. Ji, Y. Xiao, Z. Ding, L. Miao, Z. Tothova, J.W. Horner, D.R. Carrasco, et al. 2007. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell. 128:309-323. http://dx.doi.org/10.1016/j.cell.2006.12.029.
33. Paul, T.N. 1966. Treatment by local application of insulin of an infected wound in a diabetic. Lancet. 2:574-576. http://dx.doi.org/10.1016/S0140-6736(66)93041-8.
34. Peppa, M., P. Stavroulakis, and S.A. Raptis. 2009. Advanced glycoxidation products and impaired diabetic wound healing. Wound Repair Regen. 17:461-472. http://dx.doi.org/10.1111/j.1524-475X.2009.00518.x.
35. Ponugoti, B., G. Dong, and D.T. Graves. 2012. Role of forkhead transcription factors in diabetes-induced oxidative stress. Exp. Diabetes Res. 2012:939751. http://dx.doi.org/10.1155/2012/939751.
36. Ponugoti, B., F. Xu, C. Zhang, C. Tian, S. Pacios, and D.T. Graves. 2013. FOXO1 promotes wound healing through the up-regulation of TGF-β1 and prevention of oxidative stress. J. Cell Biol. 203:327-343. http://dx.doi.org/10.1083/jcb.201305074.
37. Praus, M., K. Wauterickx, D. Collen, and R.D. Gerard. 1999. Reduction of tumor cell migration and metastasis by adenoviral gene transfer of plasminogen activator inhibitors. Gene Ther. 6:227-236. http://dx.doi.org/10.1038/sj.gt.3300802.
38. Raja, K. Sivamani, M.S. Garcia, and R.R. Isseroff. 2007. Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front. Biosci. 12:2849-2868. http://dx.doi.org/10.2741/2277.
39. Reinke, J.M., and H. Sorg. 2012. Wound repair and regeneration. Eur. Surg. Res. 49:35-43. http://dx.doi.org/10.1159/000339613.
40. Rittié, L., and G.J. Fisher. 2002. UV-light-induced signal cascades and skin aging. Ageing Res. Rev. 1:705-720. http://dx.doi.org/10.1016/S1568-1637(02)00024-7.
41. Schnider, S.L., and R.R. Kohn. 1980. Glucosylation of human collagen in aging and diabetes mellitus. J. Clin. Invest. 66:1179-1181. http://dx.doi.org/10.1172/JCI109950.
42. Schnider, S.L., and R.R. Kohn. 1981. Effects of age and diabetes mellitus on the solubility and nonenzymatic glucosylation of human skin collagen. J. Clin. Invest. 67:1630-1635. http://dx.doi.org/10.1172/JCI110198.
43. Shimizu, T., K. Sato, T. Suzuki, K. Tachibana, and K. Takeda. 2003. Induction of plasminogen activator inhibitor-2 is associated with suppression of invasive activity in TPA-mediated differentiation of human prostate cancer cells. Biochem. Biophys. Res. Commun. 309:267-271. http://dx.doi.org/10.1016/j.bbrc.2003.08.004.
44. Siqueira, M.F., J. Li, L. Chehab, T. Desta, T. Chino, N. Krothpali, Y. Behl, M. Alikhani, J. Yang, C. Braasch, and D.T. Graves. 2010. Impaired wound healing in mouse models of diabetes is mediated by TNF-α dysregulation and associated with enhanced activation of forkhead box O1 (FOXO1). Diabetologia. 53:378-388. http://dx.doi.org/10.1007/s00125-009-1529-y.
45. Stojadinovic, O., H. Brem, C. Vouthounis, B. Lee, J. Fallon, M. Stallcup, A. Merchant, R.D. Galiano, and M. Tomic-Canic. 2005. Molecular pathogenesis of chronic wounds: the role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am. J. Pathol. 167:59-69. http://dx.doi.org/10.1016/S0002-9440(10)62953-7.
46. Sun, T., S. Adra, R. Smallwood, M. Holcombe, and S. MacNeil. 2009. Exploring hypotheses of the actions of TGF-β1 in epidermal wound healing using a 3D computational multiscale model of the human epidermis. PLoS ONE. 4:e8515. http://dx.doi.org/10.1371/journal.pone.0008515.
47. Tarcic, G., R. Avraham, G. Pines, I. Amit, T. Shay, Y. Lu, Y. Zwang, M. Katz, N. Ben-Chetrit, J. Jacob-Hirsch, et al. 2012. EGR1 and the ERK-ERF axis drive mammary cell migration in response to EGF. FASEB J. 26:1582-1592. http://dx.doi.org/10.1096/fj.11-194654.
48. Tredget, E.B., J. Demare, G. Chandran, E.E. Tredget, L. Yang, and A. Ghahary. 2005. Transforming growth factor-β and its effect on reepithelialization of partial-thickness ear wounds in transgenic mice. Wound Repair Regen. 13:61-67. http://dx.doi.org/10.1111/j.1067-1927.2005.130108.x.
49. Tsuchiya, K., J. Tanaka, Y. Shuiqing, C.L. Welch, R.A. DePinho, I. Tabas, A.R. Tall, I.J. Goldberg, and D. Accili. 2012. FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab. 15:372-381. http://dx.doi.org/10.1016/j.cmet.2012.01.018.
50. Usui, M.L., J.N. Mansbridge, W.G. Carter, M. Fujita, and J.E. Olerud. 2008. Keratinocyte migration, proliferation, and differentiation in chronic ulcers from patients with diabetes and normal wounds. J. Histochem. Cytochem. 56:687-696. http://dx.doi.org/10.1369/jhc.2008.951194.
51. Xu, F., C. Zhang, and D.T. Graves. 2013. Abnormal cell responses and role of TNF-α in impaired diabetic wound healing. Biomed Res. Int. 2013:754802. http://dx.doi.org/10.1155/2013/754802.
52. Yamazaki, T., X.O. Yang, Y. Chung, A. Fukunaga, R. Nurieva, B. Pappu, N. Martin-Orozco, H.S. Kang, L. Ma, A.D. Panopoulos, et al. 2008. CCR6 regulates the migration of inflammatory and regulatory T cells. J. Immunol. 181:8391-8401. http://dx.doi.org/10.4049/jimmunol.181.12.8391.
53. Yarosh, D., D. Both, J. Kibitel, C. Anderson, C. Elmets, D. Brash, and D. Brown. 2000. Regulation of TNFα production and release in human and mouse keratinocytes and mouse skin after UV-B irradiation. Photodermatol. Photoimmunol. Photomed. 16:263-270. http://dx.doi.org/10.1034/j.1600-0781.2000.160606.x.
54. Zhang, C., C.K. Tan, C. McFarlane, M. Sharma, N.S. Tan, and R. Kambadur. 2012. Myostatin-null mice exhibit delayed skin wound healing through the blockade of transforming growth factor-β signaling by decorin. Am. J. Physiol. Cell Physiol. 302:C1213-C1225. http://dx.doi.org/10.1152/ajpcell.00179.2011.